BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to Huh7 cell line is 1259
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.1739 | 33825221 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.48 | 0.1739 | 21618577 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by qRT-PCR and SFA | NA | 0.48 | 0.1739 | 29792038 |
| ABCG2 | 74 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.48 | 0.1739 | 25997710 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 33825221 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting and SFA | NA | 0.48 | 0.7582 | 22773665 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.48 | 0.7582 | 32221015 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by Western Blotting and SFA | NA | 0.48 | 0.7582 | 29602239 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA and FACs followed by Western Blotting | NA | 0.48 | 0.7582 | 32229502 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 0.7582 | 27773936 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs and qRT-PCR | NA | 0.48 | 0.7582 | 32128906 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.7582 | 28554132 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.48 | 0.7582 | 21618577 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by qRT-PCR and SFA | NA | 0.48 | 0.7582 | 29792038 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.48 | 0.7582 | 22194816 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs and SFA | NA | 0.48 | 0.7582 | 25997710 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.48 | 0.7582 | 21879266 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.48 | 0.7582 | 25404478 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by SFA | NA | 0.48 | 0.7582 | 31732298 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs | NA | 0.48 | 0.7582 | 25676692 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.48 | 0.7582 | 20697159 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.48 | 0.7582 | 25997710 |
| CTNNB1 | 2514 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay and qRT-PCR followed by SFA and IF staining | NA | 0.44 | 0.0647 | 29792038 |
| CTNNB1 | 2514 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.44 | 0.0647 | 22194816 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay and qRT-PCR followed by SFA and IF staining | NA | 0.44 | 0.6448 | 29792038 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Western Blotting | NA | 0.44 | 0.6448 | 27312708 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting and SFA | NA | 0.44 | 0.6448 | 32229502 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.44 | 0.6448 | 30908631 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.44 | 0.6448 | 27773936 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.44 | 0.6448 | 21618577 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.44 | 0.6448 | 25676692 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.44 | 0.6448 | 32128906 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.44 | 0.6448 | 22194816 |
| CD24 | 1645 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.4 | 0.456 | 26259570 |
| CD24 | 1645 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.4 | 0.456 | 25676692 |
| ALDH1A1 | 402 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.4 | 0.684 | 32221015 |
| ALDH1A1 | 402 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | ALDEFLUOR assay | NA | 0.4 | 0.684 | 34405006 |
| CD24 | 1645 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by Western Blotting and SFA | NA | 0.4 | 0.456 | 29602239 |
| CD24 | 1645 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs and qRT-PCR | NA | 0.4 | 0.456 | 32128906 |
| CD24 | 1645 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by SFA | NA | 0.4 | 0.456 | 31732298 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.4 | 1 | 32221015 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by Western Blotting and SFA | NA | 0.4 | 1 | 29602239 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Western Blotting | NA | 0.4 | 1 | 33825221 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.4 | 1 | 30908631 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.4 | 1 | 22194816 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs and SFA | NA | 0.4 | 1 | 25997710 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by SFA | NA | 0.4 | 1 | 31732298 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs | NA | 0.4 | 1 | 25676692 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.4 | 1 | 25997710 |
| CEACAM1 | 1814 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.4 | 0.0011 | 32221015 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.4 | 0.211 | 32221015 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by Western Blotting and SFA | NA | 0.4 | 0.211 | 29602239 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs and qRT-PCR | NA | 0.4 | 0.211 | 27773936 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by FACs and qRT-PCR | NA | 0.4 | 0.211 | 32128906 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.4 | 0.211 | 30908631 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.4 | 0.211 | 25676692 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.4 | 0.211 | 22194816 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs and SFA | NA | 0.4 | 0.211 | 25997710 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.4 | 0.211 | 19585654 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.4 | 0.211 | 25404478 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | MACs followed by SFA | NA | 0.4 | 0.211 | 31732298 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.4 | 0.211 | 25997710 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by Western Blotting | NA | 0.4 | 0.0371 | 32221015 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting and SFA | NA | 0.4 | 0.0371 | 32229502 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.4 | 0.0371 | 30908631 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.4 | 0.0371 | 28554132 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.4 | 0.0371 | 25676692 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.4 | 0.0371 | 32128906 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.4 | 0.0371 | 22194816 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs and SFA | NA | 0.4 | 0.0371 | 25997710 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.4 | 0.0371 | 21879266 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs | NA | 0.4 | 0.0371 | 25997710 |
| ABCF1 | 70 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0011 | 31100412 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting and SFA | NA | 0.28 | 0.1135 | 32229502 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.1135 | 30908631 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by IHC staining | NA | 0.28 | 0.1135 | 18829528 |
| HIF1A | 4910 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.0106 | 30908631 |
| MYC | 7553 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 27312708 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 27312708 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting and SFA | NA | 0.28 | 0.5461 | 32229502 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.5461 | 30908631 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.28 | 0.5461 | 21618577 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 25676692 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 32128906 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.28 | 0.5461 | 22194816 |
| NOTCH1 | 7881 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.0477 | 30908631 |
| NOTCH1 | 7881 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0477 | 32128906 |
| SIRT1 | 14929 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 27312708 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 27312708 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.5695 | 30908631 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 27773936 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.28 | 0.5695 | 21618577 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 32128906 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.28 | 0.5695 | 22194816 |
| TLR4 | 11850 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | Western Blotting and SFA | NA | 0.28 | 0.0021 | 29602239 |
| DHCR7 | 2860 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0064 | 26259570 |
| FASN | 3594 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570 |
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.24 | 0.0074 | 21618577 |
| HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570 |
| IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.0095 | 26259570 |
| MVD | 7529 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0042 | 26259570 |
| ODC1 | 8109 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0021 | 26259570 |
| DHCR7 | 2860 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692 |
| FASN | 3594 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692 |
| HMGCS1 | 5007 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692 |
| IGFBP3 | 5472 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692 |
| MIR100 | 31487 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692 |
| MIR1269A | 35337 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692 |
| MIR1269B | 41787 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692 |
| MIR15B | 31544 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692 |
| MIR210 | 31587 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692 |
| MIR215 | 31592 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692 |
| MIR22 | 31599 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692 |
| MVD | 7529 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692 |
| NDGG1 | NA | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692 |
| ODC1 | 8109 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692 |
| TGFB1 | 11766 | HTM/LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692 |
| CCND1 | 1582 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.2 | 0.0201 | 21618577 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0117 | 28554132 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.2 | 0.0117 | 21879266 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs | NA | 0.2 | 0.0117 | 25404478 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by FACs and SFA | NA | 0.2 | 0.0117 | 20697159 |
| ANPEP | 500 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | NA | 0.2 | 0.0117 | 21618577 |
| CCND1 | 1582 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by qRT-PCR and SFA | NA | 0.2 | 0.0201 | 29792038 |
| FASLG | 11936 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 32128906 |
| GLI1 | 4317 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by qRT-PCR and SFA | NA | 0.2 | 0.0308 | 29792038 |
| GPC3 | 4451 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.0032 | 21618577 |
| KIT | 6342 | LTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.018 | 21618577 |
| LINC00324 | 26628 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0021 | 32128906 |
| MALAT1 | 29665 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0074 | 32626943 |
| SMO | 11119 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SP assay followed by qRT-PCR and SFA | NA | 0.2 | 0.0212 | 29792038 |
| ABCB5 | 46 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.12 | 0.0085 | 22194816 |
| ABCC1 | 51 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.12 | 0.0212 | 22194816 |
| GRN | 4601 | LTM | Hepatic Cancer | Carcinoma | Huh7 | NA | FACs followed by CFA | NA | 0.12 | 0.0032 | 22194816 |
| A1CF | 24086 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| AAMP | 18 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ABCA5 | 35 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ABCA9 | 39 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ABCB1 | 40 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0604 | 21618577 |
| ABCC6P1 | 33352 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ABHD3 | 18718 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ABHD8 | 23759 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ABLIM3 | 29132 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ACOT11 | 18156 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ACSL4 | 3571 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| ACTN4 | 166 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577 |
| ACTR6 | 24025 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ADAM17 | 195 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ADAM22 | 201 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ADAMTS1 | 217 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ADAMTS6 | 222 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ADAMTSL3 | 14633 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ADCY10 | 21285 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ADPRM | 30925 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AFDN-DT | 21236 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AFP | 317 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| AGAP5 | 23467 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AGAP6 | 23466 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AGGF1 | 24684 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| AGR2 | 328 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570 |
| AGT | 333 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| AHDC1 | 25230 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| AHSA2P | 20437 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AK9 | 33814 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AKAP1 | 367 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| AKR1B10 | 382 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| AKR1C4 | 387 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| AKR1D1 | 388 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ALAD | 395 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ALDOC | 418 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| ALG10B | 31088 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ALG13 | 30881 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ALKBH8 | 25189 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ALPK2 | 20565 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ALPL | 438 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| AMD1 | 457 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| AMDHD1 | 28577 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| AMDHD1 | 28577 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| AMPD3 | 470 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ANGPTL4 | 16039 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ANKFY1 | 20763 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ANKRD10 | 20265 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ANKRD49 | 25970 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ANKRD50 | 29223 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ANO1 | 21625 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| ANP32A | 13233 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ANXA3 | 541 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 26259570 |
| ANXA4 | 542 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| ANXA6 | 544 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| AP2B1 | 563 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| APEH | 586 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| APOBEC3B | 17352 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| APOC1 | 607 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| AR | 644 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ARC | 648 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ARG1 | 663 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ARG2 | 664 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| ARGLU1 | 25482 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ARHGAP32 | 17399 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ARHGEF10 | 14103 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ARHGEF12 | 14193 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ARHGEF16 | 15515 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| ARHGEF19 | 26604 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ARHGEF25 | 30275 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ARL9 | 23592 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ARMCX3 | 24065 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ARMT1 | 17872 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ARRDC3 | 29263 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ASGR1 | 742 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ASPHD1 | 27380 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ASRGL1 | 16448 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| ATAT1 | 21186 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ATM | 795 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ATP2B2 | 815 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ATP6V1B1 | 853 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| AXIN2 | 904 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| B3GNT5 | 15684 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| B4GALT5 | 928 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| BAAT | 932 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| BAIAP2L2 | 26203 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| BAX | 959 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| BBIP1 | 28093 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| BCAP29 | 24131 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| BCAS1 | 974 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| BCL2L15 | 33624 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| BCL6 | 1001 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| BEX1 | 1036 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| BHLHB2 | 1046 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| BHLHB9 | 29353 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| BMF | 24132 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| BOLA1 | 24263 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| BOP1 | 15519 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| BORA | 24724 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| BRWD1 | 12760 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| BVES | 1152 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| C10ORF35 | 23519 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C12ORF34 | 25915 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C12ORF60 | 28726 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C14ORF132 | 20346 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| C15ORF29 | 26199 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C18ORF54 | 13796 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| C1D | 29911 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| C1GALT1 | 24337 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| C1ORF109 | 26039 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C1ORF54 | 26258 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| C1R | 1246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| C1S | 1247 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| C2ORF88 | 28191 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| C3 | 1318 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| C3ORF14 | 25024 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C3ORF23 | 25241 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| C4ORF33 | 27025 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692 |
| C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| C9ORF152 | 31455 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CA9 | 1383 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CAD | 1424 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| CALCOCO1 | 29306 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CAMK1 | 1459 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| CAPN15 | 11182 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CAPRIN2 | 21259 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CASP1 | 1499 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CAV1 | 1527 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0117 | 21618577 |
| CAV1 | 1527 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 26259570 |
| CAV2 | 1528 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570 |
| CBWD3 | 18519 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CBX3 | 1553 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CCDC183 | 28236 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CCDC198 | 20189 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CCDC80 | 30649 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CCDC92 | 29563 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CCL20 | 10619 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577 |
| CCN3 | 7885 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CCT6P1 | 33094 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CD58 | 1688 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CDC2 | 1722 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| CDC34 | 1734 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CDC42BPB | 1738 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CDC42EP1 | 17014 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CDH12 | 1751 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CDH15 | 1754 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CDK14 | 8883 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CDKN1C | 1786 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CDKN2B | 1788 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CDKN2B-AS1 | 34341 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CDRT4 | 14383 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CEBPD | 1835 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| CELSR2 | 3231 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CENPA | 1851 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| CFAP251 | 28506 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CFAP44 | 25631 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CFAP53 | 26530 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CFI | 5394 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CGN | 17429 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CHAC2 | 32363 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CHP2 | 24927 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CHPT1 | 17852 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CHST13 | 21755 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CITED1 | 1986 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692 |
| CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| CKAP2 | 1990 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CKAP2L | 26877 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CLDN15 | 2036 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CLDN2 | 2041 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CLDN4 | 2046 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| CLDN5 | 2047 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| CLHC1 | 26453 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CLIP3 | 24314 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CLK1 | 2068 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CLRN3 | 20795 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CNOT6 | 14099 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CNTD1 | 26847 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CNTNAP1 | 8011 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| COL15A1 | 2192 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| COL18A1 | 2195 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| COL4A5 | 2207 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| COL6A2 | 2212 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| COMMD8 | 26036 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| COPZ2 | 19356 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| COX11 | 2261 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| COX19 | 28074 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CPEB2 | 21745 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CPM | 2311 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| CREB3L3 | 18855 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CRLS1 | 16148 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CRYGS | 2417 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CSAD | 18966 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CSF2RA | 2435 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CSGALNACT1 | 24290 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| CSPP1 | 26193 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CSRP1 | 2469 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CSRP2 | 2470 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CTAG2 | 2492 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CTRL | 2524 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CTSZ | 2547 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CUTC | 24271 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| CUTC | 24271 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| CUX2 | 19347 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CX3CL1 | 10647 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| CXCL12 | 10672 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CXCL2 | 4603 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577 |
| CYFIP2 | 13760 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CYGB | 16505 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| CYP27C1 | 33480 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| CYP3A5 | 2638 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CYP3A7 | 51504 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| CYP4V2 | 51504 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| CYSRT1 | 30529 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| CYTH1 | 23198 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DAPK1 | 2674 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| DAPK1 | 2674 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| DBF4 | 17364 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DCAF13 | 24535 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| DCLRE1B | 17641 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DDIT4 | 24944 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DDR1 | 2730 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| DDR2 | 2731 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| DENND10 | 31793 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DENND5B | 28338 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DEPP1 | 23355 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| DFFA | 2772 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DFNA5 | 2674 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| DFNB59 | 2810 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DGCR8 | 2847 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DHRS1 | 16445 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DIPK2A | 28490 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DLEU1 | 13747 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DLX6-AS1 | 37151 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DMBT1 | 2926 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DNAH11 | 2942 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DNAJC28 | 1297 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| DNPH1 | 21218 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DPYD | 3012 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| DSE | 21144 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| DTL | 30288 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| DTNA | 3057 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| DTNA | 3057 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| DUS3L | 26920 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| DUSP1 | 3064 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| DUSP10 | 3065 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DUSP10 | 3065 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| DYNC1H1 | 2961 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| DYNC1LI1 | 18745 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| DYNC2I1 | 21862 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ECM2 | 3154 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| EDARADD | 14341 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EDN1 | 3176 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| EDN2 | 3177 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| EEA1 | 3185 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| EEF1A2 | 3192 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| EEF1A2 | 3192 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| EEF2K | 24615 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EEF2KMT | 32221 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| EFEMP1 | 3218 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570 |
| EFNA1 | 3221 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| EGFL8 | 13944 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| EGLN3 | 14661 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| EHF | 3246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| EID3 | 32961 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| EIF2B4 | 3260 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EIF4E | 3287 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ELFN2 | 29396 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ELFN2 | 29396 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ELOVL2 | 14416 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| ELOVL7 | 26292 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ELP1 | 5959 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| EMG1 | 16912 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EML6 | 35412 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ENKD1 | 25246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ENPP1 | 3356 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| EP400 | 11958 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| EPGN | 17470 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| EPHA1 | 3385 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| EPM2AIP1 | 19735 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EPO | 3415 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ERN1 | 3449 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ESAM | 17474 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ESYT3 | 24295 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ETAA1 | 24648 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ETFRF1 | 27052 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ETV4 | 3493 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| EVA1A | 25816 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| EXPH5 | 30578 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| F8A1 | 3547 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| F8A1 | 31849 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| F8A1 | 31850 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| FABP6 | 3561 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25676692 |
| FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570 |
| FAHD2A | 24252 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FAM102B | 27637 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| FAM13B | 1335 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FAM167A | 15549 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FAM200B | 27740 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FAM214A | 25609 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| FAM229B | 33858 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| FAM43A | 26888 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FAM69B | 28290 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FAM72D | 33593 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FAM76A | 28530 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FAM81A | 28379 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FAM83B | 21357 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| FAM98B | 26773 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FBXL21P | 13600 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FBXO32 | 16731 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FBXO8 | 13587 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FBXW9 | 28136 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| FCHO1 | 29002 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25676692 |
| FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| FES | 3657 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FGD3 | 16027 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FGF11 | 3667 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| FGF12 | 3668 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| FGF13 | 3670 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FGF2 | 3676 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| FGG | 3694 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FHDC1 | 29363 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FHOD3 | 26178 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| FKBP4 | 3720 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FKBP4 | 13949 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FLJ22536 | NA | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FLRT3 | 3762 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| FLVCR2 | 20105 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| FMO3 | 3771 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FOLR1 | 3791 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| FOXA2 | 5022 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| FSCN1 | 11148 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570 |
| FSD1 | 13745 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| FXYD3 | 4027 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| FYB2 | 27295 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| FZD4 | 4042 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| G0S2 | 30229 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| GABARAPL1 | 4068 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| GALNT11 | 19875 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GAS2L3 | 27475 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GATA2 | 4171 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GBP2 | 4183 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GC | 4187 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| GCNT3 | 4205 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GCNT4 | 17973 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| GDA | 4212 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| GFRA3 | 4245 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| GHR | 4263 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GHR | 4263 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| GJC2 | 17494 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| GKAP1 | 17496 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GLB1 | 4298 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GLRX3 | 15987 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| GLT8D2 | 24890 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GMIP | 24852 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GMPPB | 22932 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GNAL | 4388 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GNGT1 | 4411 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GNPTG | 23026 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GNRH1 | 4419 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GOLGA8IP | 26660 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| GPR183 | 3128 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| GPR87 | 4538 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| GPX2 | 4554 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| GPX3 | 4555 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| GRAMD2B | 24911 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| GRIK2 | 4580 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| GRIK4 | 4582 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| GSAP | 28042 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| GSDMB | 23690 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| GSG1L | 28283 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GSPT2 | 4622 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| GTF2H2 | 4656 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GTF2H2 | 31394 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| GTPBP8 | 25007 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GUSB | 4696 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| GUSBP1 | 13670 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| H19 | 4713 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| H19 | 4713 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| H2AC8 | 4724 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692 |
| HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| HADH | 4799 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HADHA | 4801 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| HAUS1 | 25174 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HAVCR1 | 17866 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| HCAR2 | 24827 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| HCG27 | 27366 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HCG9 | 21243 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HERC2 | 4868 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HES6 | 18254 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| HGH1 | 24161 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| HHLA2 | 4905 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HIF3A | 15825 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HIKESHI | 26938 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HIST1H1E | 4718 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HJURP | 25444 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HLA-DMA | 4934 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HLA-F | 4963 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HLA-G | 4964 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HLF | 4977 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HMGCR | 5006 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| HMGCR | 5006 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570 |
| HMGCS2 | 5008 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| HNRPLL | 25127 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HOMER3 | 17514 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HOXA13 | 5102 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HOXC9 | 5130 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692 |
| HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| HRK | 5185 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HRSP12 | 16897 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| HS1BP3 | 24979 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HSCB | 28913 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| HSPB8 | 30171 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HSPE1 | 5269 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| HTR2B | 5294 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HTRA4 | 26909 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HULC | 34232 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692 |
| HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| ICAM1 | 5344 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692 |
| ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| ID2 | 5361 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| ID4 | 5363 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| IER3 | 5392 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| IFI16 | 5395 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| IFI6 | 4054 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| IFI6 | 4054 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| IFIT2 | 5409 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| IFITM1 | 5412 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| IFTAP | 25142 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| IGF2 | 5466 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| IGF2BP2-AS1 | 32674 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| IGFBP1 | 5469 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| IGLL3P | 5872 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| IKBIP | 26430 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| IL1R1 | 5993 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| IL24 | 11346 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| IL6 | 6018 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0191 | 21618577 |
| IL8 | 6025 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577 |
| IL8 | 6025 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 26259570 |
| ING2 | 6063 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| INHA | 6065 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| INHBB | 6067 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| INHBB | 6067 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| INHBE | 24029 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| INSIG2 | 20452 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| INTS13 | 20174 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| INTS3 | 26153 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| INTS6 | 14879 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| IRAK4 | 17967 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ITGA2 | 6137 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 26259570 |
| ITGA6 | 6142 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0265 | 21618577 |
| ITGB3BP | 6157 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ITGB5 | 6160 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ITPKA | 6178 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| ITSN2 | 6184 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| IVNS1ABP | 16951 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| JAK2 | 6192 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| KBTBD11 | 29104 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KBTBD8 | 30691 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KCNAB2 | 6229 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| KCNF1 | 6246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| KCNH2 | 6251 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KCNJ5 | 6266 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KCNT2 | 18866 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KIAA0256 | 28997 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KIAA2026 | 23378 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KIF1B | 16636 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KIF5C | 6325 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KIFAP3 | 17060 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| KISS1R | 4510 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| KLF6 | 2235 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| KLF9 | 1123 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| KLHDC2 | 20231 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| KLHL11 | 19008 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KLHL15 | 29347 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| KLHL23 | 27506 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| KLKB1 | 6371 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KMO | 6381 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KMT2C | 13726 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| KMT2E-AS1 | 40845 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692 |
| KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| KNSTRN | 30767 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| KRT16 | 6423 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| KRT19 | 6436 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577 |
| KRTDAP | 16313 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| L3HYPDH | 20488 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| L3MBTL1 | 15905 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LAMA1 | 6481 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| LAMC2 | 6493 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| LAMC3 | 6494 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| LARP6 | 24012 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LAS1L | 25726 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| LDAF1 | 30136 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LFNG | 6560 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| LGALS1 | 6561 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| LGALS14 | 30054 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LGI4 | 18712 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LGR4 | 13299 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| LHX4 | 21734 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LIG1 | 6598 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| LIG4 | 6601 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LINC00261 | 16189 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LINC02210 | 26327 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LINC02249 | 32351 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LINC-PINT | 26885 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LIPC | 6619 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LIPT1 | 29569 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692 |
| LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570 |
| LOXL4 | 17171 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LPIN2 | 14450 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LRAT | 6685 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| LRBA | 1742 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| LRCH1 | 20309 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| LRIG1 | 17360 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| LRMDA | 23405 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LRP5L | 25323 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LRRC37A3 | 32427 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| LRRC37BP1 | 25390 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LRRC45 | 28302 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LRRC49 | 25965 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| LSM5 | 17162 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LSM6 | 17017 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| LSS | 6708 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| LTO1 | 17589 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| LY6E | 6727 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| LYPD6 | 28751 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MAF | 6776 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MAFB | 6408 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MAGEA1 | 6796 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MAMDC4 | 24083 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MAP3K4 | 6856 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MAP3K6 | 6858 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| MAP3K8 | 6860 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MAP3K8 | 6860 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| MAP7D2 | 25899 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MAPK8 | 6881 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MAPKAPK3 | 6888 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MARK2 | 3332 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MATK | 6906 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MB21D2 | 30438 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MBD2 | 6917 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MBD4 | 6919 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| MBL2 | 6922 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MBTPS1 | 15456 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MC1R | 6929 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MCAM | 6934 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| MCC | 6935 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| MCFD2 | 18451 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MCM7 | 6950 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| MCOLN3 | 13358 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| MCTP1 | 26183 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MDN1 | 18302 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ME1 | 6983 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| MED12 | 11957 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MED21 | 11473 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MED9 | 25487 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MEMO1 | 14014 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MEP1A | 7015 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| METTL5 | 25006 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| METTL6 | 28343 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MFNG | 7038 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MGARP | 29969 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MIPOL1 | 21460 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| MIR149 | 31536 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692 |
| MIR181C | 31552 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692 |
| MIR199A1 | 31571 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25676692 |
| MIR199B | 31573 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692 |
| MIR22HG | 28219 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MIR29C | 31621 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692 |
| MIR338 | 31775 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692 |
| MIR375 | 31868 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692 |
| MIR378A | 31871 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692 |
| MIR378D1 | 41550 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692 |
| MIR450B | 33642 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692 |
| MIR760 | 33666 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692 |
| MIX23 | 31136 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MKKS | 7108 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MMD | 7153 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| MMP23B | 7171 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MMP25 | 14246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MND1 | 24839 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MOXD1 | 21063 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MPHOSPH6 | 7214 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MPI | 7216 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MPP7 | 26542 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MPV17 | 7224 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MPZL2 | 3496 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| MRPL33 | 14487 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MRPL47 | 16652 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MRPL48 | 16653 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MSRB3 | 27375 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MST1 | 7380 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| MST1L | 7390 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MST1P2 | 7383 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MTERFD3 | 30779 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MTHFD2 | 7434 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| MTSS1 | 20443 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| MUC13 | 7511 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570 |
| MXD1 | 6761 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MYBBP1A | 7546 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| MYH3 | 7573 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| MYLK3 | 29826 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| MYO9A | 7608 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| MYPN | 23246 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| MYRF | 1181 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| N4BP1 | 29850 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| N4BP2L2-IT2 | 25038 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| NAALADL1 | 23536 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NAB1 | 7626 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NACA4P | 24688 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NAP1L5 | 19968 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| NAPB | 15751 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| NAPRT | 30450 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| NAT1 | 7645 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| NAV2 | 15997 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| NAV3 | 15998 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| NCOA2 | 7669 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| NCR3LG1 | 42400 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| NDRG1 | 7679 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| NDUFAF4 | 21034 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NDUFS6 | 7713 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NEIL2 | 18956 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NEURL4 | 34410 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| NF1 | 7765 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| NFIB | 7785 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| NIBAN1 | 16784 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| NKAIN1 | 25743 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| NKD2 | 17046 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NLE1 | 19889 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NLRP8 | 22940 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| NME6 | 20567 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NMRK1 | 26057 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NMRK2 | 17871 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NOD1 | 16390 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NOG | 7866 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NOL12 | 28585 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NOL6 | 19910 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| NOP16 | 26934 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NOX4 | 7891 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| NPC1L1 | 7898 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| NPNT | 27405 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| NPTX1 | 7952 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| NQO1 | 2874 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692 |
| NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| NR2F2 | 7976 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NR4A1 | 7980 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| NRTN | 8007 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NSUN6 | 23529 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| NTN1 | 8029 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| NTN4 | 13658 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| NUAK1 | 14311 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| NUAK2 | 29558 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NUDT6 | 8053 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| NUP214 | 8064 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NUP35 | 29797 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| NYNRIN | 20165 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| OAS1 | 8086 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| OLR1 | 8133 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| ORM1 | 8498 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ORMDL1 | 16036 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ORMDL3 | 16038 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| OSCP1 | 29971 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| OTUD4 | 24949 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| OVGP1 | 8524 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| P2RY11 | 8540 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| P3H2 | 19317 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PABPC1L | 15797 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PAK1IP1 | 20882 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PANX2 | 8600 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PAQR5 | 29645 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PAQR6 | 30132 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PAQR9 | 30131 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PARP4 | 271 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PAX9 | 8623 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PBX1 | 8632 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| PCCA | 8653 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PCDH17 | 14267 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PCDH20 | 14257 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| PCDHB16 | 14546 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PCDHB17P | 14547 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PCDHB2 | 8687 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PCDHB2 | 8688 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PCGF6 | 21156 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PCMTD2 | 15882 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PCSK6 | 8569 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PDCD11 | 13408 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PDE4C | 8782 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PDE5A | 8784 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PDE7B | 8792 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PDGFRA | 8803 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PDGFRA | 8803 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PDZD2 | 18486 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PDZK1 | 8821 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PEA15 | 8822 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PEX2 | 9717 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PFAS | 8863 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| PFDN4 | 8868 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PFN1P2 | 24298 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PFN2 | 8882 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PGAM5 | 28763 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PGM2L1 | 20898 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PHKA2 | 8926 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PHLDB2 | 29573 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PID1 | 26084 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PIEZO2 | 26270 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PIK3IP1 | 24942 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PITX1 | 9004 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PKLR | 9020 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PLA1A | 17661 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PLA2G4C | 9037 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PLAC8 | 19254 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PLCXD3 | 31822 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PLCXD3 | 31822 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PLEKHB1 | 19079 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PLIN2 | 248 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692 |
| PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570 |
| PLSCR4 | 16497 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PMAIP1 | 9108 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PMFBP1 | 17728 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PNPLA7 | 24768 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| POLR1E | 17631 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| POLR1G | 24219 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| POLR3C | 30076 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| POLR3D | 1080 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| POLR3G | 30075 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| POM121 | 19702 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| POP1 | 30129 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| PPARGC1A | 9237 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PPFIBP2 | 9250 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PPIP5K1 | 29023 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PPP1R15A | 14375 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PPP1R1C | 14940 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PPP1R3C | 9293 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PPP2R2D | 23732 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PRG2 | 9362 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PRICKLE2 | 20340 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PRKAB2 | 9379 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PRLR | 9446 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| PRODH | 9453 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| PROSER2 | 23728 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PRR7 | 28130 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PRRX1 | 9142 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PRSS53 | 34407 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PRTFDC1 | 23333 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| PSCA | 9500 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| PSMC6 | 9553 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| PSTK | 28578 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| PTHLH | 9607 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| PTP4A3 | 9636 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| PTPRH | 9672 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692 |
| PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| PUS1 | 15508 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| PYROXD2 | 23517 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| R3HDM1 | 9757 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RAB11A | 9760 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RAB3IL1 | 9780 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RAB40B | 18284 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RAB6A | 9786 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RALB | 9840 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| RALGPS1 | 16851 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| RAPGEF6 | 20655 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RARB | 9865 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| RASL11A | 23802 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| RASSF5 | 17609 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| RBBP6 | 9889 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RBM43 | 24790 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| RECQL4 | 9949 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| REEP2 | 17975 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| REV3L | 9968 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| REXO4 | 12820 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RFESD | 29587 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RFPL3S | 9981 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RGL4 | 31911 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| RGR | 9990 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RGS12 | 9994 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RHBDF2 | 20788 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RHOB | 668 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| RHOB | 668 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| RICTOR | 28611 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RILPL1 | 26814 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RIN1 | 18749 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| RIPK3 | 10021 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RIPK4 | 496 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RIPOR1 | 25836 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RN7SK | 10037 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RNASEH1 | 18466 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RNASEH2B | 25671 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RNASEH2C | 24116 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RND1 | 18314 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RNF111 | 17384 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RNF125 | 21150 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RNF144B | 21578 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| RNF149 | 23137 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RNF217 | 21487 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| RNF7 | 10070 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| RNFT1 | 30206 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RNLS | 25641 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ROBO2 | 10250 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| RPL36A | 10359 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RPL6 | 10362 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| RPS7 | 10440 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| RRAGB | 19901 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RRM2 | 10452 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RRP12 | 29100 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| RRP9 | 16829 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RRP9 | 16829 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| RTL8C | 2569 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| RTN4R | 18601 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| RUNX1 | 10471 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| RWDD2A | 21385 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| RWDD3 | 21393 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| S100A11 | 10488 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| S100A7L2 | 21655 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SC5DL | 10547 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SCARNA9 | 32566 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SCIN | 21695 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| SCN2A | 10588 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SCNN1D | 10601 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SCRIB | 30377 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SEC16A | 29006 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SECISBP2 | 30972 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SECTM1 | 10707 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| SELENBP1 | 10719 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| SELL | 10720 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SEMA3F | 10728 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SEMA7A | 10741 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| SEPHS2 | 19686 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SEPTIN7P2 | 32339 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SERPINA5 | 8723 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SERPINE1 | 8583 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| SERPINF1 | 8824 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692 |
| SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SERTAD4 | 25236 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SESN1 | 21595 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SF3B6 | 30096 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25676692 |
| SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570 |
| SFXN2 | 16086 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SGSH | 10818 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SH2D4A | 26102 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| SH2D5 | 28819 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| SH3BGRL2 | 15567 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SH3BP5L | 29360 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SHOC1 | 26535 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SHPK | 1492 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SKAP2 | 15687 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SLC17A3 | 10931 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLC1A3 | 10941 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| SLC22A15 | 20301 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SLC22A23 | 21106 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SLC22A23 | 21106 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SLC25A19 | 14409 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLC25A47 | 20115 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SLC2A12 | 18067 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SLC2A2 | 11006 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SLC30A10 | 25355 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SLC35F6 | 26055 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLC39A4 | 17129 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SLC39A8 | 20862 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692 |
| SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| SLC47A1 | 25588 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| SLC49A4 | 16628 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLC5A11 | 23091 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| SLC6A12 | 11045 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| SLC6A12 | 11045 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| SLC6A14 | 11047 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SLC6A20 | 30927 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SLC7A5 | 11063 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| SLC7A8 | 11066 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| SLC9B2 | 25143 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SLCO4A1 | 10953 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| SMAD6 | 6772 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| SMAD7 | 6773 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| SMAP1 | 19651 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SMC1A | 11111 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SMG9 | 25763 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SMIM24 | 37244 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SNAI2 | 11094 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577 |
| SNAP23 | 11131 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SNAP25 | 11132 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SND1 | 30646 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SND1-IT1 | 24158 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SNHG5 | 21026 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SNHG6 | 32965 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SNORA25 | 32615 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SNX24 | 21533 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SOCS2 | 19382 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570 |
| SOCS4 | 19392 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SORL1 | 11185 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SOX4 | 11200 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| SOX9 | 11204 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0244 | 21618577 |
| SP8 | 19196 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SPACA6 | 27113 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SPAG1 | 11212 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SPATA2 | 14681 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SPDYE1 | 16408 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SPG11 | 11226 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SPRR1B | 11260 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| SPRY4 | 15533 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SPTBN2 | 11276 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SPTSSA | 20361 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| SPTSSB | 24045 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SQLE | 11279 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| SREBF2 | 11290 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SRPK2 | 11306 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SSH2 | 30580 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| SSTR5 | 11334 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| SSX1 | 11335 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ST20 | 33520 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ST3GAL6 | 18080 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ST6GAL1 | 10860 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| STARD8 | 19161 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| STBD1 | 24854 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| STEAP2 | 17885 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| STK33 | 14568 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| STX11 | 11429 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| SUSD1 | 25413 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| SYBU | 26011 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| SYNE3 | 19861 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| SYNE4 | 26703 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| SYNGR4 | 11502 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TAF1A | 11532 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TAF5L | 17304 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TAF9 | 11542 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TANC2 | 30212 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TAS2R14 | 14920 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| TAS2R5 | 14912 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TATDN1 | 24220 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TATDN3 | 27010 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TAX1BP3 | 30684 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TCEA3 | 11615 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TCOF1 | 11654 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| TCP11L2 | 28627 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TDP2 | 17768 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TEDC1 | 20127 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| TENT5A | 18345 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TF | 11740 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TFF2 | 11756 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TFF3 | 11757 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577 |
| TFF3 | 11757 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570 |
| TFR2 | 11762 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TGFB2 | 11768 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570 |
| TGFBI | 11771 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| THAP6 | 23189 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| THBS1 | 11785 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| THBS4 | 11788 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| THSD4 | 25835 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TIAM2 | 11806 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TICRR | 28704 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TIMP4 | 11823 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TINAGL1 | 19168 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TKT | 11834 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570 |
| TLE6 | 30788 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TM2D3 | 24128 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TM4SF4 | 11856 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TM4SF5 | 11857 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TMBIM1 | 23410 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TMED10 | 16998 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TMED10P1 | 30754 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TMEM126B | 30883 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TMEM128 | 28201 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TMEM131L | 29146 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TMEM256 | 28618 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TMEM263 | 28281 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TMEM268 | 24513 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TMEM51 | 25488 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TMEM79 | 28196 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TMEM82 | 32350 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| TMEM97 | 28106 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| TNFAIP3 | 11896 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577 |
| TNFAIP3 | 11896 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570 |
| TNFRSF11B | 11909 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| TNFRSF12A | 18152 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TNFRSF13C | 17755 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TNFSF4 | 11934 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TNIK | 30765 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577 |
| TNKS1BP1 | 19081 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TNNT1 | 11948 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692 |
| TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TONSL | 7801 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| TOR4A | 25981 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| TOX2 | 16095 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TP53INP1 | 18022 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TPM1 | 12010 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570 |
| TPP1 | 2073 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TPR | 12017 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| TPRKB | 24259 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TPRKB | 24259 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TPST1 | 12020 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TRAF7 | 20456 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TRAPPC2 | 23068 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TRAPPC9 | 30832 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692 |
| TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| TRIM29 | 17274 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577 |
| TRIM31 | 16289 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TRIM37 | 7523 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TRIM4 | 16275 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TRIM58 | 24150 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| TRIM7 | 16278 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TRMT61B | 26070 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TRPV2 | 18082 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TSPAN10 | 29942 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TTC12 | 23700 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TTC27 | 25986 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TTC3 | 12393 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TTC39C | 26595 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| TTLL3 | 24483 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| TXNDC16 | 19965 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| TXNDC9 | 24110 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| TXNDC9 | 24110 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| TYSND1 | 28531 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UBA2 | 30661 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| UBAP2L | 29877 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UBD | 18795 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| UBE2Q2 | 19248 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UBE3D | 21381 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UBXN2A | 27265 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UCA1 | 37126 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| UCN | 12516 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UGT1A1 | 12530 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| UGT1A1 | 12530 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| UGT1A10 | 12531 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| UGT1A6 | 12538 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570 |
| UGT2B10 | 12544 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| UMPS | 12563 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| UNC80 | 26582 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| UQCR11 | 30862 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| USP49 | 20078 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| VAMP1 | 12642 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| VAV3 | 12659 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| VCX3B | 31838 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| VEPH1 | 25735 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| VGF | 12684 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| VN1R2 | 19872 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| VNN3 | 16431 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| VPS37D | 18287 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| VRK2 | 12719 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| VWA1 | 30910 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| WDR5B | 17826 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| WDR72 | 26790 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| WDSUB1 | 26697 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| WEE1 | 12761 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| WHAMMP2 | 32360 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| WSB2 | 19222 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| XRCC3 | 12830 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570 |
| YAF2 | 17363 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| YPEL2 | 18326 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| YTHDC1 | 30626 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZBTB18 | 13030 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZBTB20 | 13503 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZBTB5 | 23836 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZBTB8OS | 24094 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZC3H12A | 26259 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZC3H8 | 30941 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZCCHC9 | 25424 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZCWPW1 | 23486 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZDHHC13 | 18413 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ZDHHC2 | 18469 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZFC3H1 | 28328 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZFYVE21 | 20760 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZFYVE26 | 20761 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZIC4 | 20393 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF121 | 12904 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF124 | 12907 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF140 | 12925 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ZNF140 | 12925 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| ZNF17 | 12958 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF189 | 12980 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ZNF212 | 13004 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570 |
| ZNF271P | 13065 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF277 | 13070 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF287 | 13502 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF295-AS1 | 23130 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF302 | 13848 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ZNF304 | 13505 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF324 | 14096 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF331 | 15489 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ZNF334 | 15806 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF33B | 13097 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF35 | 13099 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF354C | 16736 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF385B | 26332 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF397 | 18818 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ZNF417 | 20646 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF432 | 20810 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF443 | 20878 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF543 | 25281 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF580 | 29473 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF581 | 25017 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF585A | 26305 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF614 | 24722 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570 |
| ZNF627 | 30570 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF630 | 28855 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF649 | 25741 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570 |
| ZNF671 | 26279 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF69 | 13138 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF695 | 30954 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577 |
| ZNF740 | 27465 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF75A | 13146 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577 |
| ZNF75D | 13145 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF771 | 29653 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF777 | 22213 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF784 | 33111 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF805 | 23272 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF81 | 13156 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZNF814 | 33258 | HTM | Hepatic Cancer | Carcinoma | Huh7 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570 |
| ZNF875 | 4928 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |
| ZP3 | 13189 | HTM | Hepatic Cancer | Carcinoma | Huh7 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577 |